A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)

Author:

Velez-Santiago Alondra1,Alvarez-Torres Edwin1,Martinez-Rodriguez Ricardo1,Candal-Rivera Emmanuel2,Muniz-Camacho Luis2,Ramos-Burgos Luis3,Torres Esther A.1

Affiliation:

1. Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus, PR Medical Center, San Juan, PR 00935, USA

2. Veterans Affairs Caribbean Health System, 10 Calle Casia, San Juan, PR 00921-3201, USA

3. Massachussetts General Hospital, 55 Fruit St., Boston, MA 02114, USA

Abstract

Inflammatory bowel diseases (IBDs) are chronic conditions of unknown cause or cure. Treatment seeks to reduce symptoms and induce and maintain remission. Many patients have turned to alternatives, such as cannabis, to alleviate living with IBD. This study reports the demographics, prevalence, and perception on cannabis use of patients attending an IBD clinic. Patients agreed to participate and completed an anonymous survey during their visit or online. Descriptive analysis, Fisher’s exact test, and Wilcoxon-Mann-Whitney rank-sum test were used. One hundred and sixty-two adults (85 males, 77 with CD) completed the survey. Sixty (37%) reported use of cannabis, of which 38 (63%) used it to relieve their IBD. A value of 77% reported low to moderate knowledge about cannabis, and 15% reported little to no knowledge. Among cannabis users, 48% had discussed use with their physician, but 88% said they would feel comfortable discussing medical cannabis for IBD. Most saw improvement of their symptoms (85.7%). A considerable number of patients with IBD use medical cannabis for their disease, unknown to their physician. The study reinforces the importance that physicians understand the role of cannabis in the treatment of IBD in order to appropriately counsel patients.

Funder

National Center for Minority Health and Health Disparities

National Institutes of Health

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference27 articles.

1. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease;Storr;Inflamm. Bowel Dis.,2014

2. Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis;Weiss;Drug Alcohol Depend.,2015

3. Therapeutic Use of Cannabis in Inflammatory Bowel Disease;Ahmed;Gastroenterol. Hepatol.,2016

4. Cannabis use amongst patients with inflammatory bowel disease;Lal;Eur. J. Gastroenterol. Hepatol.,2011

5. Cannabis for the Treatment of Crohn’s Disease and Ulcerative Colitis: Evidence from Cochrane Reviews;Kafil;Inflamm. Bowel Dis.,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3